4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001477449-24-000186
EVP, CORPORATE DEVELOPMENT sold 1,617 shares at $7.16 ($11,584)
- EVP, CORPORATE DEVELOPMENT acquired 5,504 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Turitz Andrew · EVP, CORPORATE DEVELOPMENT
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 1 in the form | +1,056 | 38,715 | D | ||
| 2024-08-30 | Exercise or conversion : show line 2 in the form | +1,348 | 40,063 | D | ||
| 2024-08-30 | Exercise or conversion : show line 3 in the form | +3,100 | 43,163 | D | ||
| 2024-09-03 | Sale : show line 4 in the form | −1,617 | $7.16 | $11,584 | 41,546 | D |
| Open-market sales · 1,617 sh · avg $7.16 · $11,584 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 5 in the form Performance Stock Units | −1,056 | 6,341 | D |
| 2024-08-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −1,348 | 2,696 | D |
| 2024-08-30 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −3,100 | 18,602 | D |
Loading xslF345X05/wk-form4_1725480694.xml…